BL
Balentine LLC Portfolio holdings
AUM
$2.57B
This Quarter Return
+7.25%
1 Year Return
+11.26%
3 Year Return
+43.25%
5 Year Return
+72.63%
10 Year Return
+167.54%
AUM
$1.78B
AUM Growth
+$1.78B
(+6.3%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
93.28%
Holding
802
New
74
Increased
287
Reduced
84
Closed
201
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$7.48M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$6.33M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$6.02M |
| 4 |
SPDR Dow Jones REIT ETF
RWR
|
$4.56M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$2.74M |
Top Sells
Sector Composition
| 1 | Technology | 0.47% |
| 2 | Industrials | 0.27% |
| 3 | Financials | 0.27% |
| 4 | Healthcare | 0.26% |
| 5 | Consumer Discretionary | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vanguard Total World Stock ETF
VT
$50.9B
| $95K | 0.01% |
1,174
| – | – |
|
127
S&P Global
SPGI
$165B
| $94K | 0.01% |
344
+307
| +830% | +$83.9K |
|
128
Boston Scientific
BSX
$157B
| $90K | 0.01% |
2,000
+1,713
| +597% | +$77.1K |
|
129
Goldman Sachs
GS
$220B
| $90K | 0.01% |
393
-328
| -45% | -$75.1K |
|
130
Edwards Lifesciences
EW
$47.9B
| $88K | ﹤0.01% |
376
+200
| +114% | +$46.8K |
|
131
Zimmer Biomet
ZBH
$21B
| $87K | ﹤0.01% |
583
+521
| +840% | +$77.7K |
|
132
Zoetis
ZTS
$67.4B
| $87K | ﹤0.01% |
661
+543
| +460% | +$71.5K |
|
133
Gilead Sciences
GILD
$139B
| $86K | ﹤0.01% |
1,331
+899
| +208% | +$58.1K |
|
134
CVS Health
CVS
$94.1B
| $83K | ﹤0.01% |
1,119
-2,288
| -67% | -$170K |
|
135
Fiserv
FI
$73.2B
| $83K | ﹤0.01% |
719
+633
| +736% | +$73.1K |
|
136
Aon
AON
$79.5B
| $82K | ﹤0.01% |
395
+361
| +1,062% | +$74.9K |
|
137
Fastenal
FAST
$56.5B
| $82K | ﹤0.01% |
2,222
+1,338
| +151% | +$49.4K |
|
138
Intuit
INTU
$184B
| $82K | ﹤0.01% |
314
+280
| +824% | +$73.1K |
|
139
Intuitive Surgical
ISRG
$167B
| $78K | ﹤0.01% |
132
+112
| +560% | +$66.2K |
|
140
Carlyle Group
CG
$23B
| $77K | ﹤0.01% |
+2,400
| New | +$77K |
|
141
Schlumberger
SLB
$53.5B
| $77K | ﹤0.01% |
1,925
+1,389
| +259% | +$55.6K |
|
142
TE Connectivity
TEL
$60B
| $77K | ﹤0.01% |
807
+8
| +1% | +$763 |
|
143
Blackstone
BX
$131B
| $76K | ﹤0.01% |
+1,352
| New | +$76K |
|
144
CSX Corp
CSX
$59.9B
| $76K | ﹤0.01% |
1,050
+880
| +518% | +$63.7K |
|
145
Jazz Pharmaceuticals
JAZZ
$7.89B
| $76K | ﹤0.01% |
+507
| New | +$76K |
|
146
Sherwin-Williams
SHW
$89.6B
| $76K | ﹤0.01% |
130
+93
| +251% | +$54.4K |
|
147
Waste Management
WM
$90.6B
| $75K | ﹤0.01% |
658
+601
| +1,054% | +$68.5K |
|
148
KKR & Co
KKR
$122B
| $73K | ﹤0.01% |
+2,517
| New | +$73K |
|
149
Ecolab
ECL
$77.9B
| $69K | ﹤0.01% |
359
+297
| +479% | +$57.1K |
|
150
Charter Communications
CHTR
$36B
| $68K | ﹤0.01% |
141
+117
| +488% | +$56.4K |
|